How an earnings call comment from Al Sandrock propelled an appeals court’s reversal on a Biogen investor suitnews2023-10-12T17:19:41+00:00October 12th, 2023|Endpoints News|
FDA’s drug promotion watchdog plans study around adherence claims in pharma adsnews2023-10-12T17:15:40+00:00October 12th, 2023|Endpoints News|
GSK looks to authorized generic version of asthma treatment Flovent as Medicaid rebate caps lift next yearnews2023-10-12T17:11:48+00:00October 12th, 2023|Endpoints News|
Pfizer adds another cancer approval for its Braftovi and Mektovi combo therapynews2023-10-12T17:04:46+00:00October 12th, 2023|Endpoints News|
Recipharm CEO anticipates 2024 will be ‘as hard’ for CDMOs, strategy will be key for endurancenews2023-10-12T16:42:08+00:00October 12th, 2023|Endpoints News|
AbbVie and Incyte unveil ‘undifferentiated’ PhIIb data of their oral JAKs in vitiligonews2023-10-12T15:50:02+00:00October 12th, 2023|Endpoints News|
FDA lifts hold on PepGen’s myotonic dystrophy drug; Takeda teams with cancer nonprofitnews2023-10-12T15:23:14+00:00October 12th, 2023|Endpoints News|
Eli Lilly’s IL-23 drug mirikizumab passes Phase III test in Crohn’snews2023-10-12T15:09:37+00:00October 12th, 2023|Endpoints News|
Fujifilm Irvine workforce cuts; Gates Foundation invests in Africa-made vaccines; Sharp acquires BSMnews2023-10-12T14:33:32+00:00October 12th, 2023|Endpoints News|
Walmart will expand virtual care to employees in bid to cut costs, improve outcomesnews2023-10-12T13:15:00+00:00October 12th, 2023|Endpoints News|
